Prospective Open-labelled Randomized Controlled trial for efficacy of cholesterol lowering intervention in CKD patient with dyslipidemia.

Trial Profile

Prospective Open-labelled Randomized Controlled trial for efficacy of cholesterol lowering intervention in CKD patient with dyslipidemia.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 13 Mar 2013

At a glance

  • Drugs Ezetimibe (Primary) ; Pitavastatin (Primary)
  • Indications Lipid metabolism disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Mar 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top